Immunity：黄波团队利用生物机械力信号强势扩增干性 CAR-T 细胞，有望颠覆实体肿瘤细胞治疗

Core Viewpoint - The article discusses a groundbreaking research achievement in CAR-T cell therapy, particularly focusing on the development of stem cell-like CAR-T cells that can effectively target solid tumors, overcoming previous limitations in the field [3][11]. Group 1: Research Breakthrough - The research led by Professor Huang Bo's team successfully utilized biomechanical signals to decouple the proliferation and differentiation of CAR-T cells, allowing for the rapid generation of stem cell-like CAR-T cells in just 4.5 days [3][11]. - This innovative approach addresses the challenges faced by traditional CAR-T therapies in solid tumors, which often struggle with cell exhaustion and limited infiltration into tumor tissues [3][11]. Group 2: Mechanism of Action - The study reveals that biomechanical signals, particularly through β2 integrin, play a crucial role in promoting CAR-T cell proliferation while simultaneously inhibiting differentiation [8][9]. - The phosphorylation of β2 integrin leads to the activation of the YAP protein, which in turn promotes the expression of stemness genes such as SOX2 and NANOG, essential for maintaining the stem cell-like characteristics of CAR-T cells [8][9]. Group 3: Clinical Implications - The newly developed CAR-T cells demonstrated significant efficacy in various mouse models of solid tumors, including colorectal cancer, glioblastoma, and pancreatic cancer, indicating their potential for clinical application [8][11]. - The method of producing these CAR-T cells is cost-effective, requiring no expensive external factors and utilizing lower cell quantities, which could make CAR-T therapy more accessible to a broader patient population [8][11].